Moscow (Reuters) – Russia’s sovereign wealth fund said on Wednesday it will supply India’s Dr. Reddy’s Laboratories with 100 million doses of the Sputnik-V vaccine against COVID-19 once it receives regulatory approval in India.
The Russian Direct Investment Fund (RDIF) added that it had agreed to cooperate on clinical trials and the distribution of the vaccine with the Indian firm.
Date:
RecentRelated
For Kuwait’s new emir, Saudi ties are seen as key
Kuwait (Reuters) - Sheikh Meshal al-Ahmad al-Sabah was named...
Pope Francis deplores Israeli killings of civilians at Gaza church
Vatican City (Reuters) - Pope Francis on Sunday again...
Palestinians must find new path from Israeli rule after war, top official says
Ramallah (Reuters) - Immediately after Israel's war in Gaza...
Israel says it struck Hezbollah sites after attacks from Lebanon
Jerusalem/Beirut (Reuters) - Israel said on Sunday it had...